Poria D, Kolesnikov A, Lee T, Salom D, Palczewski K, Kefalov V
eNeuro. 2023; 10(3).
PMID: 36823167
PMC: 9997694.
DOI: 10.1523/ENEURO.0330-22.2023.
Nguyen H, Hurh S, Nguyen L, Nguyen T, Park H, Seong J
Mol Cells. 2023; 46(5):281-297.
PMID: 36799104
PMC: 10183793.
DOI: 10.14348/molcells.2023.2096.
Connelly S, Sridharan R, Naider F, Dumont M
Biophys J. 2021; 120(22):5090-5106.
PMID: 34627767
PMC: 8633717.
DOI: 10.1016/j.bpj.2021.10.005.
Garcia-Cuesta E, Santiago C, Vallejo-Diaz J, Juarranz Y, Rodriguez-Frade J, Mellado M
Front Endocrinol (Lausanne). 2019; 10:585.
PMID: 31507535
PMC: 6718456.
DOI: 10.3389/fendo.2019.00585.
Ge B, Lao J, Li J, Chen Y, Song Y, Huang F
Sci Rep. 2017; 7(1):16873.
PMID: 29203889
PMC: 5715067.
DOI: 10.1038/s41598-017-16802-7.
CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response.
Ceholski D, Turnbull I, Pothula V, Lecce L, Jarrah A, Kho C
Stem Cell Res. 2017; 23:77-86.
PMID: 28711757
PMC: 5859259.
DOI: 10.1016/j.scr.2017.06.015.
Modulation of Chemokine Responses: Synergy and Cooperativity.
Proudfoot A, Uguccioni M
Front Immunol. 2016; 7:183.
PMID: 27242790
PMC: 4871875.
DOI: 10.3389/fimmu.2016.00183.
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
Coke C, Scarlett K, Chetram M, Jones K, Sandifer B, Davis A
J Biol Chem. 2016; 291(19):9991-10005.
PMID: 26841863
PMC: 4859002.
DOI: 10.1074/jbc.M115.712661.
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.
Cecchinato V, DAgostino G, Raeli L, Uguccioni M
J Leukoc Biol. 2015; 99(6):851-5.
PMID: 26715684
PMC: 5039040.
DOI: 10.1189/jlb.1MR1015-457R.
Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.
Singh S, Foley J, Zhang H, Hurt D, Richards J, Smith C
Mol Pharmacol. 2015; 88(5):894-910.
PMID: 26316539
PMC: 4613941.
DOI: 10.1124/mol.115.099960.
Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells.
Oynebraten I, Barois N, Bergeland T, Kuchler A, Bakke O, Haraldsen G
Sci Rep. 2015; 5:9261.
PMID: 25791723
PMC: 4367157.
DOI: 10.1038/srep09261.
Crystal structure of LGR4-Rspo1 complex: insights into the divergent mechanisms of ligand recognition by leucine-rich repeat G-protein-coupled receptors (LGRs).
Xu J, Huang C, Yang Z, Jin M, Fu P, Zhang N
J Biol Chem. 2014; 290(4):2455-65.
PMID: 25480784
PMC: 4303694.
DOI: 10.1074/jbc.M114.599134.
Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.
Arnatt C, Zhang Y
Curr Top Med Chem. 2014; 14(13):1606-18.
PMID: 25159160
PMC: 4373595.
DOI: 10.2174/1568026614666140827144752.
Chemokine receptors in epithelial ovarian cancer.
Muralidhar G, Barbolina M
Int J Mol Sci. 2014; 15(1):361-76.
PMID: 24384839
PMC: 3907814.
DOI: 10.3390/ijms15010361.
Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward.
Schellekens H, Dinan T, Cryan J
Front Neurosci. 2013; 7:148.
PMID: 24009547
PMC: 3757321.
DOI: 10.3389/fnins.2013.00148.
Visualization of BRI1 and BAK1(SERK3) membrane receptor heterooligomers during brassinosteroid signaling.
Bucherl C, van Esse G, Kruis A, Luchtenberg J, Westphal A, Aker J
Plant Physiol. 2013; 162(4):1911-25.
PMID: 23796795
PMC: 3729770.
DOI: 10.1104/pp.113.220152.
The downstream regulation of chemokine receptor signalling: implications for atherosclerosis.
Patel J, Channon K, McNeill E
Mediators Inflamm. 2013; 2013:459520.
PMID: 23690662
PMC: 3649756.
DOI: 10.1155/2013/459520.
A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer.
Kufareva I, Stephens B, Gilliland C, Wu B, Fenalti G, Hamel D
Methods Mol Biol. 2013; 1013:93-127.
PMID: 23625495
PMC: 4091634.
DOI: 10.1007/978-1-62703-426-5_7.
Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7.
De Poorter C, Baertsoen K, Lannoy V, Parmentier M, Springael J
PLoS One. 2013; 8(2):e58075.
PMID: 23469143
PMC: 3585228.
DOI: 10.1371/journal.pone.0058075.
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.
Vinet J, van Zwam M, Dijkstra I, Brouwer N, van Weering H, Watts A
Br J Pharmacol. 2012; 168(6):1375-87.
PMID: 23121557
PMC: 3596643.
DOI: 10.1111/bph.12042.